These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18687447)

  • 21. Identification of a potential "hotspot" DNA region in the RUNX1 gene targeted by mitoxantrone in therapy-related acute myeloid leukemia with t(16;21) translocation.
    Ottone T; Hasan SK; Montefusco E; Curzi P; Mays AN; Chessa L; Ferrari A; Conte E; Noguera NI; Lavorgna S; Ammatuna E; Divona M; Bovetti K; Amadori S; Grimwade D; Lo-Coco F
    Genes Chromosomes Cancer; 2009 Mar; 48(3):213-21. PubMed ID: 19023877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute myeloid leukaemia induced by mitoxantrone: case report.
    Arruda WO; Montú MB; de Oliveira Mde S; Ramina R
    Arq Neuropsiquiatr; 2005 Jun; 63(2A):327-9. PubMed ID: 16100984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitoxantrone (Novantrone) in multiple sclerosis: new insights.
    Neuhaus O; Kieseier BC; Hartung HP
    Expert Rev Neurother; 2004 Jan; 4(1):17-26. PubMed ID: 15853611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased incidence of central nervous system hemorrhages in patients with secondary acute promyelocytic leukemia after treatment of multiple sclerosis with mitoxantrone?
    Taube F; Stölzel F; Thiede C; Ehninger G; Laniado M; Schaich M
    Haematologica; 2011 Jun; 96(6):e31. PubMed ID: 21632839
    [No Abstract]   [Full Text] [Related]  

  • 25. The first case of mitoxantrone exposure in early pregnancy.
    De Santis M; Straface G; Cavaliere AF; Rosati P; Batocchi AP; Caruso A
    Neurotoxicology; 2007 May; 28(3):696-7. PubMed ID: 17227680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Marburg variant multiple sclerosis with mitoxantrone.
    Jeffery DR; Lefkowitz DS; Crittenden JP
    J Neuroimaging; 2004 Jan; 14(1):58-62. PubMed ID: 14748210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitoxantrone for multiple sclerosis causing acute lymphoblastic leukemia.
    Cartwright MS; Jeffery DR; Lewis ZT; Koty PP; Stewart WT; Molnár I
    Neurology; 2007 May; 68(19):1630-1. PubMed ID: 17485652
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and safety of mitoxantrone, as an initial therapy, in multiple sclerosis: experience in an Indian tertiary care setting.
    Singhal BS; Geeta S; Hundalani SG; Menon S
    Neurol India; 2009; 57(4):418-23. PubMed ID: 19770542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.
    Pula JH; Javed A
    Curr Opin Ophthalmol; 2009 Nov; 20(6):476-81. PubMed ID: 19816177
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of mitoxantrone in early multiple sclerosis with malignant disease course. Observational study in 30 patients with clinical and MRI outcomes after one year].
    Ory S; Debouverie M; Le Page E; Pelletier J; Malikova I; Gout O; Roullet E; Vermersch P; Edan G
    Rev Neurol (Paris); 2008 Dec; 164(12):1028-34. PubMed ID: 18808781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of mitoxantrone in multiple sclerosis--what is known?
    Neuhaus O; Kieseier BC; Hartung HP
    J Neurol Sci; 2004 Aug; 223(1):25-7. PubMed ID: 15261556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of multiple sclerosis].
    Simó M
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):23-6. PubMed ID: 19731815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy-related acute leukaemia with mitoxantrone: four years on, what is the risk and can it be limited?
    Ellis R; Brown S; Boggild M
    Mult Scler; 2015 Apr; 21(5):642-5. PubMed ID: 25013152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe cardiac failure in a patient with multiple sclerosis following low-dose mitoxantrone treatment.
    Killestein J; van der Meer ML; Regelink JC; Huijgens PC; Polman CH
    Neurology; 2010 Mar; 74(11):934; author reply 934. PubMed ID: 20231672
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute leukaemia in two multiple sclerosis patients treated with mitoxantrone].
    Nollet S; Berger E; Deconinck E; Baldauf E; Rumbach L
    Rev Neurol (Paris); 2006 Feb; 162(2):195-9. PubMed ID: 16518259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
    Betancourt-García RD; Castro J; Fernández AC; López-Enríquez A; Fradera J; Pacheco E
    P R Health Sci J; 2009 Jun; 28(2):146-50. PubMed ID: 19530558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone.
    Martinelli V; Cocco E; Capra R; Salemi G; Gallo P; Capobianco M; Pesci I; Ghezzi A; Pozzilli C; Lugaresi A; Bellantonio P; Amato MP; Grimaldi LM; Trojano M; Mancardi GL; Bergamaschi R; Gasperini C; Rodegher M; Straffi L; Ponzio M; Comi G;
    Neurology; 2011 Nov; 77(21):1887-95. PubMed ID: 22076543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MS.
    Brassat D; Recher C; Waubant E; Le Page E; Rigal-Huguet F; Laurent G; Edan G; Clanet M
    Neurology; 2002 Sep; 59(6):954-5. PubMed ID: 12297591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent melanonychia by mitoxantrone.
    Reinsberger C; Meuth SG; Wiendl H
    Mult Scler; 2009 Sep; 15(9):1131-2. PubMed ID: 19570819
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotherapy and multiple sclerosis: The devil is in the details.
    Bourdette D; Whitham R
    Neurology; 2010 May; 74(18):1410-1. PubMed ID: 20439842
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.